uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Evaluation of pharmacist and physician written referrals within the MedBridge study
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
2019 (English)Independent thesis Advanced level (degree of Master (One Year)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Introduction: Inadequate communication in transition of care can entail negative medication related patient outcomes. Medication related referrals (MRRs) to primary care, sent at the time of discharge from hospital, can decrease this risk. MRRs generate proposed actions (PAs) which can be divided into two categories: PAs related to the cause of admission (RPAs) and PAs non-related to the cause of admission (NRPAs). Although most MRRs are sent by physicians – the patients’ responsible caregiver – clinical pharmacists sometimes also send MRRs. The Medication Reviews Bridging Healthcare (MedBridge) study aims to evaluate the use of clinical pharmacists in a hospital setting, with the addition of pharmacist MRRs in one of the intervention groups (I2).

Aim: To determine the prevalence and characteristics of MRRs, within the MedBridge study, and differences between the study groups (I1 and I2); and to determine the extent of PAs which were acted upon in primary care.

Materials and Methods: This study focused on patients with pharmacist and physician MRRs, in I1 and I2 of the MedBridge study, with their index admission at Uppsala University hospital and Enköping hospital. The patients’ MRRs, and attached PAs, were characterized and followed from hospital to primary care. Data were recorded and analysed in Microsoft Excel.

Results: Out of 830 patients 304 had MRRs, generating 461 physician PAs and 91 pharmacist PAs. The MRRs in I1 and I2 generated 246 PAs (NRPAs 17.5%) and 306 PAs (NRPAs 29.1%), respectively. The percentages of PAs which were acted upon in primary care in I1 and I2 were 68.7% (NRPAs 41.9%, RPAs 74.4%) and 74.5% (NRPAs 68.5%, RPAs 77.0%), respectively.

Conclusions: The added pharmacist interventions in I2 seemed to increase the number of PAs and NRPAs in total, as well as the total percentage of NRPAs which were acted upon in primary care, which have the possibility to improve patient safety and mitigate the vulnerability in the transition of care process.

Place, publisher, year, edition, pages
2019. , p. 27
Keywords [en]
clinical pharmacy, referrals, primary care, MedBridge
Keywords [sv]
klinisk farmaci, remisser, primärvård, MedBridge
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-377168OAI: oai:DiVA.org:uu-377168DiVA, id: diva2:1289050
External cooperation
Uppsala University Hospital
Subject / course
Pharmacotherapy
Educational program
Master of Science Programme in Pharmacy
Supervisors
Examiners
Available from: 2019-02-15 Created: 2019-02-15 Last updated: 2019-02-15Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Department of Pharmaceutical Biosciences
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 66 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf